Life sciences organisation Cytiva has acquired a new facility in Michigan US to help it expand its resins manufacturing operations outside of Sweden. The company’s new chromatography resins manufacturing site will be based in Muskegon, Michigan and forms part of Cytiva and Pall Corporation’s $1.5 billion capacity expansion investment. Cytiva plans to transform the site […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!